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M inimally invasive mitral valve (MV) repair and replace-ment (MIMVR) was first described as a potential alterna-
tive to full-sternotomy MV surgery in the mid-1990s.1 Since
that time, 4 techniques have emerged as acceptable ap-
proaches to MIMVR: lower hemisternotomy, direct-vision
right minithoracotomy, endoscopic right minithoracotomy,
and robotic-assisted right minithoracotomy.See accompanying editorial on page 233, and articles on
pages 243 and 260No randomized clinical trials have yet been undertaken to
directly compare the safety and effectiveness of minimally inva-
sive approaches with each other or full sternotomy. Thus, there
have, to date, been minimal data to guide practicing surgeons
and few descriptions of standardized techniques.
Recognizing that the field of MIMVR has matured such
that greater standardization is desirable, a group of 26 US sur-
geons with combined experience of approximately 17,000
MIMVR operations convened aworking group to compile initial
guidance based on expert consensus. The group does not pro-
pose to either establish the superior efficacy or safety of one
MIMVR approach over another, or to compare them to a full-
sternotomy approach; instead, the goal was to describe a step-
wise approach for surgeons wishing to gain new knowledge
about current MIMVR approaches.
The present report is the second of a 3-part series of arti-
cles that are intended to be read together. This current work fo-
cuses on the 3 nonrobotic operative approaches to MIMVR.
Patient selection and evaluation, and preoperative planning for
successful cannulation, systemic perfusion, myocardial protec-
tion, and anesthetic preparation, were addressed in the first part251
thoracic Surgery. Unauthorized reproduction of this article is prohibited.
Disclosures:All authors declare that they serve as consultants on theMedical
Advisory Board for Edwards Lifesciences Corp, Irvine, CA USA. In addi-
tion, S. Chris Malaisrie, MD, is a consultant for Medtronic, Inc, Minneapolis,
MN USA, and Abbott Vascular, Abbott Park, IL USA. R. Saeid Farivar,
MD, PhD, is a consultant to Abbott Vascular, Abbott Park, IL USA, and
Medtronic, Inc,Minneapolis,MNUSA.W.ClarkHargrove,MD,was a consul-
tant to Sorin/LivaNova, Milan, Italy. Michael G. Moront, MD, is a consultant
for Medtronic Heart Valves, Medtronic, Inc, Minneapolis, MN USA, Terumo
Cardiovascular Group, Ann Arbor, MI USA, and LSI SOLUTIONS, Victor,
NYUSA.WilliamH. Ryan, MD, is a consultant toMedtronic, Inc, Minneapolis,
MN USA. Gorav Ailawadi, MD, is a consultant to Abbott Vascular, Ab-
bott Park, IL USA, AtriCure, Inc, West Chester, OH USA, Medtronic,
Inc, Minneapolis, MN USA, and St. Jude Medical, Inc, St. Paul, MN
USA. BrianW. Hummel, MD, is a consultant to AtriCure, Inc,West Chester,
OH USA, and Medtronic, Inc, Minneapolis, MN USA. Eugene A. Grossi,
MD, is a consultant to Medtronic, Inc, Minneapolis, MN USA, and Intuitive
Surgical, Sunnyvale, CA USA. T. Sloane Guy, MD, is a consultant to
Medtronic Inc, Minneapolis, MN USA, and Ethicon Inc/Johnson&Johnson,
Somerville, NJ USA, and a recipient of a grant from Biomet, Inc,Warsaw, IN
USA. John R. Mehall, MD, is a consultant to AtriCure, Inc, West Chester,
OH USA. Douglas A. Murphy, MD, receives product royalties from
Medtronic, Inc, Minneapolis, MN USA. Evelio Rodriguez, MD, is a consul-
tant to Abbott Vascular, Abbott Park, IL USA, AtriCure, Inc, West Chester,
OH USA, and St. Jude Medical, Inc, St. Paul, MN USA, is a grant recipient
fromMedtronic, Inc,Minneapolis, MNUSA, and serves on the speaker’s bu-
reaus for Edwards Lifesciences, Corp, Irvine, CA USA, and Medtronic,
Inc, Minneapolis,MNUSA. Arash Salemi, MD, is a consultant toMedtronic,
Inc, Minneapolis, MN USA. J. Michael Smith, MD, is a consultant to
AtriCure, Inc, West Chester, OH USA, and Intuitive Surgical, Sunnyvale,
CAUSA. Robert L. Smith, MD, serves on the speaker’s bureaus for Abbott
Vascular, Abbott Park, IL USA, and Intuitive Surgical, Inc, Sunnyvale, CA
USA. Clifton T. P. Lewis, MD, is a consultant to Intuitive Surgical, Inc, Sunnyvale,
CA USA. Glenn R. Barnhart, MD, is a consultant to AtriCure, Inc, West
Chester, OH USA, and On-X Life Technologies, Austin, TX USA. Scott M.
Goldman, MD, serves on advisory boards for Abbott Vascular, Abbott Park,
IL USA, and Medtronic, Inc, Minneapolis, MN USA, and is a consultant to
St. Jude, Inc, St. Paul, MN USA, and LSI SOLUTIONS, Victor, NY USA. J.
Alan Wolfe, MD, Junaid H. Khan, MD, Arvind K. Agnihotri, MD, Trevor
M. Fayers, MD, Eric J. Lehr, MD, PhD, Romualdo J. Segurola, Jr, MD, Richard
J. Shemin,MD, and PaulW.Weldner,MD, declare no other conflicts of interest.
Wolfe et al Innovations • Volume 11, Number 4, July/August 2016
Cof the series.2 The third report will describe considerations
specific to robotic-assisted MIMVR, as well as training path-
ways that will prepare the surgical team to move from full-
sternotomy to minithoracotomy to robotic approaches.3
FIRST PRINCIPLES OF CARDIAC SURGERY AND
MIMVR
Aswith any cardiac operation, MIMVR is based on 4 fun-
damental tenets: (1) establishment and maintenance of adequate
cannulation and perfusion, (2) complete myocardial protection,
(3) optimal exposure, and (4) procedures appropriate to the pa-
tient's specific pathology.4 A methodical approach to perform-
ing each step within the overall MIMVR is a key concept. The
consequences of poorly conducted cardiopulmonary bypass
(CPB), failure to confirm adequate venous drainage before
cardiotomy, inadequate myocardial protection, and suboptimal
surgical exposure are magnified in MIMVR. Each step must
be completed before proceeding to the next to avoid extending
operative times or otherwise compromising the operation. Facil-
itating the application of these principles, use of an efficient
stepwise procedural approach, and maintenance of open team
communication are essential to success.
Since most MIMVRs are not done with central cannula-
tion for CPB, familiarity with the techniques of peripheral can-
nulation and thorough preoperative planning form the basis of
a safe procedure.2 With only basic endovascular wire skills,
the surgeon should establish CPB with the goal of complete
unloading of the heart and reliable systemic perfusion. The252 Copyright © 2016 by th
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poor myocardial protection, and malperfusion syndrome.
When transitioning from full sternotomy to MIMVR, a
dependable method of myocardial protection is necessary.2
Longer periods of myocardial ischemia are required for
MIMVR, and consequences of poor myocardial protection
are right-sided heart dysfunction or even biventricular failure.
Rarely is a strategy depending on ventricular fibrillation with-
out aortic cross clamping used as a sole means of protection.
Surgical exposure of the MV in mini-thoracotomy ap-
proaches can be equal to or better than sternotomy approaches.
Exposure is predicated upon appropriate placement of the work-
ing incision in relation to the pulmonary hilum and greatly facil-
itated using endoscopy. During the transition to MIMVR, it is
helpful to be familiar with the use of enabling technologies,
some of which may also be used in the sternotomy approach.
Long-shafted instruments, auto-knotting devices, transthoracic
aortic cross clamps, and endoaortic occlusion balloons not only
facilitate the procedure but also improve visibility and exposure.
As with all cardiac surgery, a team that is familiar with
minimally invasive techniques and technology will facilitate
safe conduct of MIMVR. It is important that the team is briefed
on the operative plan for each minimally invasive valve proce-
dure, and that communication among the team members is es-
tablished and encouraged. Members of the team should be
empowered to voice any concerns.
SPECIFIC SURGICAL APPROACHES TO MIMVR
The 3 approaches described here roughly follow a natural
progression in the development of skills necessary to moving
from a full sternotomy to a minithoracotomy approach.5,6
Lower Hemisternotomy Technique
Lower hemisternotomy is an option for MIMVR as well as
atrial septal defect closure, tricuspid valve repair or replacement,
and atrial fibrillation ablation with left atrial appendage closure.7
Limited coronary artery bypass grafting is also possible. The key
advantage of this approach is the ability to directly cannulate and
cross-clamp the aorta. Morbid obesity is a relative contraindica-
tion, and this approach is contraindicated in reoperations because
of the difficulty that may be encountered in exposing the aorta.
The operative strategy, setup, and anesthesia protocols
are similar to full-sternotomy MV procedures, with a few
modifications. Defibrillator pads are placed on the patient be-
fore surgery. The angle of Louis (sternomanubrial junction)
marks the second rib, and a 6- to 8-cm vertical skin incision
is made in the midline, starting 2.5 cm caudal to the angle
of Louis toward the xyphoid process (Fig. 1). A reciprocating
saw, with the blade pointing up, is used to enter the right-sided
attachments of the xiphoid process and a sternotomy is made
cephalad toward the angle of Louis. The sternotomy is extended
into the right second intercostal space and can be performed by
gently curving the reciprocating saw or using an oscillating saw
with a narrow blade. The manubrium is kept intact while main-
taining adequate exposure from the second intercostal space to
the xiphoid process. Care is taken not to injure the right inter-
nal mammary (thoracic) artery or vein. Owing to the small
skin incision, a standard sternal retractor cannot be placed.
A variety of low-profile sternal retractors with narrow bladese International Society for Minimally Invasive Cardiothoracic Surgery
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FIGURE 2. Lower hemisternotomy showing placement of retractor
and cannulae.
FIGURE 1. Lower hemisternotomy incision.
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Cand attachments for self-retaining left-atrial retractors are avail-
able and are recommended. Carbon dioxide (CO2) is routinely
flooded into the operating field to assist in de-airing of the heart
at the end of the procedure.
The pericardium is opened vertically, and since the manu-
brium is left intact, the operative field may be moved caudad to im-
prove exposure. Tonsil clamps are used to grasp the pericardium
and pull it caudad. Three silk sutures are placed on the right side
of the pericardium, with a skew toward the cranial half so as to
pull the pericardium caudally. The needles are kept on the su-
ture, and the retractor is removed. The sutures are then sewn
on the caudal half of the skin incision and pulled up tightly.
The retractor is then re-replaced and opened. This exposes the
heart and pulls the aorta caudally into the incision (Fig. 2).
A double purse-string is placed in the ascending aorta. A
tonsil clamp can grasp the fat pad to assist retraction. A standard
ascending aortic cannula is then placed and secured to the skin.
Venous cannulation and drainage is typically approached
femorally, either percutaneously or by cutdown, and is aug-
mented as needed by the addition of a neck superior vena cava
(SVC) cannula. A root vent is placed into the ascending aorta
for de-airing and antegrade cardioplegia. A retrograde cardioplegia
cannula can be placed according to the surgeon's preference.2
Once CPB is initiated, mild hypothermia is instituted. Vac-
uum or kinetic-assist venous drainage augments emptying of the
heart. Aortic occlusion can be accomplished by placing an aortic
cross clamp in the standard manner. The aortopulmonary junction
is not opened, and a left atrial vent is not used. Once the clamp is
placed, antegrade cardioplegia is given. The interatrial groove is
developed, and the right atrium can be freed from the left atrium
(LA) up to the fossa ovalis. The LA is widely opened, from the
SVC to the oblique fossa under the inferior vena cava, to facilitate
exposure of the MV.
Mitral valve repair or replacement techniques are standard
per surgeon's preference. After completion of the MV surgery,Copyright © 2016 by the International Society for Minimally Invasive Card
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tubes, and temporary epicardial pacing wires are performed in
the standard manner. Typically, 2 soft chest drains are placed,
with one placed into the oblique sinus and the other anteriorly.
Closure is typically performed with 4 simple wires,
completely encircling the sternum at the intercostal spaces. At
the junction at the second intercostal space, a wire is placed at
a 45-degree angle to ensure vertical stability and minimize post-
operative sternal clicking. Alternatively, a sternal plate can be
used to secure the entire sternum.
Direct-Vision Right Minithoracotomy Technique
A right lateral approach is an attractive option for MIMVR
because it causes less surgical trauma compared to sternotomy,
allowing patients to return to functional status within 2 weeks in-
stead of 1 to 2 months.8 Other advantages include “straight-on”
visualization of the MV, decreased blood loss, lower incidence
of significant wound infections, and improved cosmesis.9–14
Anesthesia protocol is generally the same as in conventional
MV repair. Earlier extubation can be accomplished by modifying
the anesthetic agents being used. Single-lung ventilation using ei-
ther a double-lumen tube or a bronchial blocker greatly facilitates
the procedure. Before starting CPB, the right lung can be deflated
to identify landmarks. In reoperations, lung adhesions can be easily
divided. Finally, hemostasis is facilitated at the end of the procedure
with the lung deflated. Some surgeons prefer not to use single-lung
ventilation; however, this technique comes at the expense of in-
creased CPB times.
Bilateral arterial lines are required when using endoaortic
balloon occlusion. Care should be taken to avoid dampening these
tracings, and monitors should be set to ensure that these tracings
overlap with those for the root vent. Transvenous placement of a
pulmonary vent, or addition of an SVC cannula into the venous
circuit using a Y connector, may significantly aid in drainageiothoracic Surgery 253
thoracic Surgery. Unauthorized reproduction of this article is prohibited.
Wolfe et al Innovations • Volume 11, Number 4, July/August 2016
C(discussed later in the text). Significant variations exist in the
use of retrograde cardioplegia; some experienced centers use it
in every case, others not at all. In the case of mild to moderate
aortic insufficiency and reoperative cases, retrograde cardio-
plegia can be beneficial, and it can be placed either directly
through the right atrial free wall or percutaneously through the
right internal jugular vein.
The patient is positioned supine (Fig. 3) all the way to the
right side of the table, with the right arm fully supported by the
table and slightly flexed to improve access to the anterior axillary
line. A small pillow or IV bag is placed inferior to the scapula to
open up the axillary space. The head should remain in the mid-
line and should be supported to minimize risk of brachial plexus
injury. Placement of defibrillator pads across the chest wall is
routine, as access to the ventricles is limited. A plastic adhesive
incise drape is helpful in retracting breast tissue superiorly and
medially to facilitate exposure and “relocate” the inframammary
crease to the appropriate intercostal space.
The primary incision is placed at the level of the hilum,
usually in the fourth intercostal space, starting at themidclavicular
line and extending laterally to the anterior axillary line. Large in-
cisions can be used in the beginning, becoming smaller and more
lateral with greater experience. The incision should be large
enough to allow for adequate light to reach the MV. A head lamp
may be useful with this technique.
Next, attention is directed to chest wall hemostasis. Place-
ment of a clean lap tape can help identify troublesome spots. A soft
tissue retractor is placed, and slight rib spreading may be required.
Carbon dioxide insufflation, which is useful in minimizing air in
minithoracotomy as well as endoscopic cases, is established at 2
to 3 L/min.
An incision parallel to the inguinal ligament exposes the
common femoral vessels. Intraoperative ultrasound can facilitate
a smaller incision in the groin and help to identify the ideal po-
sition on the vessel proximal to the profunda femoris. Using only
electrocautery for the dissection and avoiding injury to the tissueFIGURE 3. Patient positioning for direct-vision right minithoracotom
(transparent ellipse). The vertical dashed line indicates the placement
254 Copyright © 2016 by th
opyright © 2016 by the International Society for Minimally Invasive Cardiobetween the artery and vein will help prevent the development of
a lymphocele.
Venous cannula placement is carried out over a wire with
guidance from transesophageal echocardiogram (TEE). The
vein is accessed with an 18-gauge needle, and a J-tip wire is
passed to the right side of the heart. The wire can be seen on a
bicaval echocardiographic view, although with additional lines
traversing the right atrium, caution must be taken that misidenti-
fication does not occur. The J-tip should be visualized by all
team members as it traverses the right atrium into the SVC.
The tapered introducer protrudes from the line by several centi-
meters, and the cannula is gently advanced this distance as the
introducer is removed. The TEE appearance of the venous can-
nula will not be readily apparent until the introducer is removed;
the typical “railroad track” appearance will confirm optimal po-
sition in the SVC. The end of the cannula should be positioned 2
to 3 cm above the atrial-SVC junction to insure adequate
brachiocephalic drainage if it is retracted by subsequent atrial
septal “lifting” for valve exposure.
When the occasion arises, a percutaneous modified
Seldinger technique can be used to gain access to the femoral vein.
Care must be taken to avoid bending the J-tip wire, which could re-
sult in poor track development, especially in obese patients. Ex-
changing the J-tip wire with a stiff guidewire can be used to
avoid this problem. Upon removal, a deep skin stitch, such as a hor-
izontal mattress or figure-of-eight using a 2-0 suture, is all that is
necessary for closure with removal of the suture on day 3 or day 4.
No operation should proceed in the presence of inadequate
venous drainage. Before anticipated aortic clamping, complete
decompression of the right atrium must be confirmed by a low
transduced central venous pressure, a nonpulsatile arterial wave-
form, and direct visualization of the right atrial chamber.
Vacuum-assisted suction is used for venous drainage. In general,
the amount of suction should not exceed 40 mm Hg. If adequate
decompression of the right atrium is not possible with addition
of vacuum, the venous cannula is repositioned. The use of ay, showing a small pillow placed inferior to the scapula
of the primary incision.
e International Society for Minimally Invasive Cardiothoracic Surgery
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Cmultiside-hole venous cannula can reduce the need to reposition
and may provide improved drainage.
Drainage can deteriorate during the conduct of the opera-
tion. This typically occurs during movement of the left atrial re-
tractor, which can interfere with the drainage from the upper
body. If a distended SVC can be visualized, either a different an-
gle of retraction or repositioning of the cannula is needed. Drain-
age can also be poor in larger patients when an SVC cannula is
not used, despite all efforts to remediate. In that setting, it is pru-
dent to place an additional thoracic trocar and directly cannulate
the SVCwith a separate, wire-reinforced, 24-F cannula and con-
nected into the venous circuit with a Y connector.
After visual confirmation that the right side of the heart is
empty and there is no cardiac ejection, the pericardium is opened
and stay sutures are placed. A figure-of-eight suture or pledgeted
horizontal mattress suture using 0 silk is placed at the superior
portion of the dome of the diaphragm and passed through the
chest wall inferiorly to allow for gentle caudal retraction (Fig. 4).
This “flattening” of the diaphragm allows for complete direct vi-
sualization from the costophrenic pericardial reflection to the
level of the mid ascending aorta. Visual observation and atten-
tion to individual anatomical differences must be exercised to
avoid excessive tension on the right phrenic nerve.
Direct aortic cross clamping or endoaortic balloon occlu-
sion is followed by antegrade cardioplegia and retrograde
cardioplegia, if used. The oblique sinus is widely entered poste-
rior to the inferior vena cava. It is important that the incision be
carried far enough inferiorly to “release” the posterior atrial wall
and prevent posterior atrial wall “tenting.” Turning the pulmonary
artery vent off will facilitate entering the LA. The atrial retractor
post is placed through a separate entry in the same intercostal
space as theworking port, as medial as possible, avoiding injury
to the internal mammary artery. The atrial retractor blade is cho-
sen based on the size and depth of the LA to achieve superior
visualization. The blade should sit near the posteromedial com-
missure. The atrial retractor post is retracted anteriorly and con-
nected to an external retractor stabilization device. If MV
visualization is not ideal, repositioning of the retractor post
and expansion of the working port should be achieved before
initiating repair.FIGURE 4. Exteriorization of sutures for diaphragmatic retraction.
Copyright © 2016 by the International Society for Minimally Invasive Card
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dard according to surgeon's preference. Shafted instruments
and use of an autoknotting device will facilitate the procedure.
Additional procedures may be also performed such as atrial
fibrillation ablation, left atrial appendage closure, and tricus-
pid valve repair according to surgeon preference, keeping in
mind that concurrent tricuspid valve repair requires bicaval
cannulation, and the addition of concurrent procedures will
lengthen already prolonged clamp times. These may be added
after the team obtains significant experiencewith isolated primary
MVoperations.
Pacingwires should be placed on the inferiorwall of the right
ventricle before removing the clamp or other occlusion device. In
reoperative cases, a Swan-Ganz (Edwards, Irvine, CAUSA) cath-
eter or previously placed transvenous pacing wire is required.
Routine use of CO2 minimizes residual intracardiac air.
15
De-airing is accomplished by filling the heart while closing the
atriotomy and by sumping the left ventricle. Gentle suction is
placed on the aortic vent or the central lumen of the endoaortic bal-
loon catheter as appropriate. The clamp is removed, and the heart
is allowed to recover. Cardiopulmonary bypass is discontinued.
Closure of the pericardium may be performed by either
loosely applying sutures, or with a patch. One soft chest drain
is left in the pericardium, and a second should be left in the
pleural space. The ribs should be loosely approximated to pre-
vent lung herniation. Before closure, the chest wall should be
examined meticulously for bleeding; an angled mirror or
scope can be helpful for looking at the port, retractor, and stay
suture sites.
Endoscopic Right Minithoracotomy Technique
Adoption of an “endoscopic” approach to port access sur-
gery allows full expression of the surgical skill sets one has de-
veloped during the progression from sternotomy to a minimally
invasive approach.5,6 As such, it should be noted that a number
of the technique-related suggestions presented here may also be
useful to surgeons performing direct-vision minithoracotomy.
The term endoscopic refers to the intracardiac portion of
the procedure, which is performed through the smallest possible
working incision, ideally requiring a soft tissue retractor and
minimal to no rib spreading. The extracardiac portion of the op-
eration, in both exposure and atrial closure, can be performed
endoscopically, but these steps are more easily accomplished un-
der direct vision through the working port. This approach allows
for increased accuracy and efficiency during the preparatory and
closing portions of the procedure while ultimately providing un-
obstructed visualization of the valve.
The working incision is usually placed in the fourth or
fifth intercostal space at the anterior axillary line and extended
4 cm laterally (Fig. 5). This allows for subsequent insertion of
a 35- to 45-mm atrial retractor “blade,” and will admit 1 or 2 fin-
gers in almost all cases. This incision usually falls just at the
dome of the diaphragm, which may need to be retracted.
Using internal finger palpation, the seventh intercostal
space is located inferiorly at the midaxillary line, and an entry
site is created through which a left atrial sump is placed. The
sump tip is extracted from the working port, and any soft tissue
debris along the suction ports are cleared, after which it is
allowed to retract back into the chest. Carbon dioxide is infusediothoracic Surgery 255
thoracic Surgery. Unauthorized reproduction of this article is prohibited.
FIGURE 6. Retraction of the interatrial septum.
FIGURE 7. Endoscopic visualization of the MV.
FIGURE 5. Incisions for working port and retractor. The red dot
represents the location of the incision for the retractor.
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Cin the field at a flow rate of 2 to 3 L/min through a soft drain that
can remain as a drainage tube.
A soft tissue retractor is inserted to retract the intercostal
muscles, allowing for smooth introduction of long-shafted in-
struments and helping to preclude the inadvertent insertion of
soft tissue debris during the intracardiac procedure.
Cannulation, myocardial protection, and de-airing are
identical to those described in the direct-vision approach. The
oblique sinus is opened widely, epicardial fat is cleared down
to the atrial wall, and the Sondergaard groove is developed min-
imally to allow for accurate incision of the LA. A 5-mm trocar is
placed through a separate stab wound one intercostal space
above andmore lateral than theworking port, providing a “direct
view” of the valve with a thoracoscope. A zero- or 30-degree
thoracoscope should provide unimpeded lighting and visualiza-
tion, and a table-mounted scope holder facilitates stabilization.
After aortic occlusion and cardioplegia arrest, a left
atriotomy is performed and carried from the dome of the LA in-
feriorly through the oblique sinus, inferior to the right pulmo-
nary veins. As discussed in the direct vision section, atrial wall
“tenting” should be avoided. Internal finger palpation medially
along the fourth intercostal space usually confirms proper place-
ment of the atrial retractor blade post just lateral to the right
sternal border. This minimizes the possibility of trauma to
the internal thoracic artery and can be confirmed endoscopi-
cally before creating an entry site. The atrial retractor blade
can now be delivered through the working port, connected
to the post, and used to gently retract the interatrial septum an-
teriorly. A bedside stabilization device best affords stable fix-
ation. Only minimal retraction is required, and the MV is
rarely distorted (Fig. 6).256 Copyright © 2016 by th
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atriotomy and positioned within the left inferior pulmonary
vein. The thoracoscope is advanced into the LA, and the re-
mainder of the operation is performed videoscopically, with
excellent visualization that allows a systematic, complete as-
sessment of mitral leaflet morphology as well as the subval-
vular apparatus (Fig. 7).
Long-shafted instruments are manipulated through the
working port into the LA, allowing for any desired surgical tech-
nique according to surgeon preference. Direct visualization of
the valve using this approach may be possible.
SPECIAL CONSIDERATIONS
Transthoracic Cross-Clamping
Aortic occlusion can be achieved with a transthoracic
cross clamp or through endoaortic balloon occlusion, the com-
parative advantages and disadvantages of which are discussed
in Ailadwadi et al.2 Early in their experience, most MIMVRe International Society for Minimally Invasive Cardiothoracic Surgery
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Csurgeons begin with cross clamping, which is familiar and al-
lows direct clamping of the aorta as one would typically do
through a sternotomy. This approach necessitates placement of
a cardioplegia needle or catheter into the ascending aorta proxi-
mal to the cross clamp. Alternatively, a 14-gauge angiocatheter
can be placed percutaneously along the sternum, taking care to
avoid injury to the right internal mammary artery or intercostal
vessels when traversing the chest wall. This technique is desir-
able in that the catheter is removed from the direct operative
field; however, less optimal aortic venting may result owing to
its long narrow design, and its flimsy nature may result in the
catheter becoming kinked or completely dislodged. Repair of
this site can facilitated by use of plegeted 2-0 polyester sutures
and the use of an autoknotting device. As such, repair of this site
is typically done while on pump to control aortic pressure while
tying down sutures.
The clamp must be placed carefully in the transverse si-
nus, avoiding injury to the pulmonary artery and the left atrial
appendage. If using a rigid clamp, kinking of the SVC can occur
if significant atrial septal retraction is used. This can lead to re-
stricted venous return unless the venous cannula is placed well
into the SVC or a separate SVC cannula is used.
Endoaortic Balloon Occlusion
Use of endoaortic balloon (Edwards, Irvine, CAUSA) oc-
clusion presents its own unique set of benefits and challenges.2
While a comprehensive guide to the use of an endoaorticFIGURE 8. Endoaortic occlusion balloon positioning. A, Correct ballo
balloon and possible iatrogenic puncture. C, Distal migration may di
cannula 2 to 3 cm above the junction of the right atrium and superio
Copyright © 2016 by the International Society for Minimally Invasive Card
opyright © 2016 by the International Society for Minimally Invasive Cardioocclusion balloon is beyond the scope of this article, a brief
description of its use and of the various forces acting on it
may help surgeons in improving stability of the balloon within
the aortic lumen.
The endoaortic balloon device is introduced through a he-
mostatic valved side arm on the arterial return catheter. It is po-
sitioned over a guidewire that has been previously advanced into
the ascending aorta under either TEE or fluoroscopic guidance.
The tip of the catheter is advanced until it is confirmed, by
TEE, to be just above the sinotubular junction (STJ) as shown
in Figure 8. The guidewire is then removed, leaving the central
lumen for either cardioplegia administration or suction venting.
Once the central lumen has been confirmed to be de-aired, both
the balloon and root pressure tubing lines are connected to trans-
ducers and CPB is slowly instituted while a satisfactory and ac-
ceptable arterial-line perfusion pressure is confirmed.
There are numerous techniques of balloon deployment
that allow for satisfactory and stable positioning. An occlusive
endoaortic balloon will offer some resistance to migration by
its radial force. Measuring the aortic diameter at the level of
the STJ will provide a useful approximation of the necessary bal-
loon volume required to provide stable occlusion. Balloon infla-
tion with 1-mL saline per millimeter of aortic diameter will
provide occlusion in most cases. This target volume is adminis-
tered incrementally, anticipating an adequately inflated balloon
pressure of 350 to 450 mm Hg. Overdistension with possible
aortic trauma is to be avoided. A compliance/hysteresis changeon position. B, Proximal migration may allow leakage around the
minish brachiocephalic perfusion. Note the tip of the venous
r vena cava.
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Cwithin the wall of the balloon often results in a gradually de-
creasing inflation pressures to the 200 to 250 range, which
should be ignored assuming a stable arrested heart. A properly
inflated occlusive balloon will subsequently migrate according
to the “relative forces” applied.
Emptying the venous circulation will mitigate balloon
migration during initial inflation. The diminished ventricular
stroke volume allows for balloon inflation to proceed under
TEE guidance, maintaining its position above the STJ while
confirming that pressures in the bilateral arterial lines remain
similar. Once target inflation pressures are obtained, CPB flow
rates can be restored, whereas antegrade cardioplegia infused
into the aortic root provides “balance” against the forces of in-
creasing systemic perfusion pressure on the balloon. An initial
dose of adenosine (20–30 mg) may be infused to promote
asystole during initial balloon deployment. At this point, ob-
servation of a “gradient” developing between the aortic root
and systemic perfusion pressures is further indirect evidence
of effective balloon occlusion.
During and immediately after cardioplegic arrest, the most
dominant force on the balloon is from the pressure of arterial
perfusion, which will usually exceed aortic root pressure from
the cardioplegia pump. Increased arterial perfusion pressure will
promote migration toward the valve, potentially resulting in cir-
cumferential leakage or subsequent iatrogenic injury. Transesoph-
ageal echocardiogram will show migration of the endoaortic
balloon toward the aortic valve as arterial pressure increases
and should be compensated for by catheter retraction to main-
tain the rim of the endoaortic balloon above the STJ. Active aor-
tic root venting also will promote migration toward the valve.
After cessation of antegrade cardioplegia, and certainly once
the heart is open, systemic arterial perfusion pressure and cath-
eter retraction are the dominant forces and must be balanced be-
fore final positioning. Once the balloon catheter is “locked” into
position, it is imperative that arterial perfusion be maintained at
relatively constant pressures.
Decreased arterial perfusion promotes migration away
from the valve, which could lead to innominate artery occlusion
and decreased right brachiocephalic blood flow. Subsequent
dosing of antegrade cardioplegia in the presence of a competent
aortic valve may result in transient balloon migration toward the
innominate artery that subsides once the cardioplegia infusion is
complete. This rise in aortic root pressure is important to con-
firm that the aortic root anatomy and thus valve competence is
maintained and not adversely affected by the atrial septal retrac-
tor. Intermittent dosing of retrograde cardioplegia should have
no effect on balloon position.
Femoral Arterial Cannulation and Avoidance of
Ischemic Leg Injury in MIMVR
Ischemic injury to the leg is a documented potential com-
plication of femoral arterial cannulation. The proposed mecha-
nisms for this injury include misidentification of the common
femoral artery, cannulation of a small femoral system, excessive
perfusion times, unidentified vascular disease within this arterial
system, and vascular injury or narrowing after removal of the
cannula. In the patient without significant vascular disease,
clamping or cannulating the common femoral artery should be
reasonably well tolerated, with good backflow through the258 Copyright © 2016 by th
opyright © 2016 by the International Society for Minimally Invasive Cardioprofunda system via collaterals. If the patient is cannulated ei-
ther too close to the superficial femoral artery takeoff or if the
superficial femoral artery is incorrectly identified as the com-
mon femoral artery, significant ischemic injury can occur.
Compounding these issues is the relative obstruction of venous
return caused by a concomitant cannulation of the ipsilateral
femoral vein. These may lead to ischemic complications.
Avoidance of ischemic injury to the leg should be of
primary concern for any minimally invasive approach. Care-
ful preoperative screening (including CT angiography) and
absolute certainty regarding cannulation of the common fem-
oral vessel without occlusion of the femoral bifurcation
should eliminate most if not all occurrences of this rare com-
plication. Adjunctive precautions include measures to im-
prove distal perfusion and monitoring for distal ischemia
with near-infrared oximetry. Some centers use creation of a
T graft using an 8-mm vascular graft sewn to the common
femoral artery. This graft is then cannulated for arterial in-
flow, allowing blood to flow bidirectionally in the femoral
system. Alternatively, distal (inferior) cannulation of the fem-
oral artery is done with a small catheter (5-F arterial access
sheath), using a short line taken off the arterial inflow.
Postoperative Management
Postoperative care should be tailored toward an accel-
erated recovery that takes advantage of the reduced surgi-
cal trauma associated with MIMVR. As previously noted,
extubation in the operating room or within the first 6 hours
is the goal and is facilitated by modified sedation and anal-
gesia protocols. The keys to successful early extubation include
an appropriate balance of sedation and analgesia to facilitate early
extubation while allowing the patient to emerge with minimal
incisional pain. A useful option for sedation is dexmedetomidine,
which is unique in its ability to provide sedation without causing
respiratory depression. Options for nonsedating parenteral an-
algesia include intravenous acetaminophen and intravenous
ketorolac. Avoidance of long-term muscle relaxants during
the procedure and complete rewarming of the patient will also
facilitate early extubation.
After extubation, the benefits of adequate local pain con-
trol instituted in the operating room become apparent. A long-
acting intercostal block should routinely be administered before
closure and options include bupivacaine, which has duration of
approximately 6 hours, and liposomal bupivacaine, which can
last up to 72 hours. Reservoir devices that allow continuous de-
livery of local anesthetic agents are also beneficial. Finally,
cryoanalgesia is another adjunct for local analgesia and can be
performed by freezing the intercostal nerve using a cryothermy
probe before chest closure.16
Standard postoperative cardiac care applies for the
MIMVR patient. Atrial fibrillation is common after cardiotomy
and is treated per protocol. Prophylactic amiodarone is another
strategy to reduce the rate of new-onset atrial fibrillation.17
Chest tubes are removed when drainage is less than 100mL over
8 hours and serosanguinous. The goal is removal of all chest
tubes, invasive lines, urinary catheter, and pacing wires by post-
operative day 1. Aggressive diuresis should be maintained for
3 to 5 days while in the hospital, and this may reduce the risk
of recurrent pleural effusions, which is a common reason fore International Society for Minimally Invasive Cardiothoracic Surgery
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Creadmission. Patients should have the expectation of discharge
by postoperative day 3 or 4.
Standard sternal wound precautions are unnecessary for tho-
racotomy patients. Physical restrictions on upper extremity range of
motion are relaxed upon discharge, and heavy lifting is titrated to
pain tolerance. Patients may resume driving once they have ceased
taking oral narcotics. No physical restrictions apply after 2 weeks.
CONCLUSIONS
Three established methods of performing MIMVR
have been described. These include lower hemisternotomy,
direct-vision right minithoracotomy, and endoscopic right
minithoracotomy approaches. By consensus, a group of experi-
enced surgeons has outlined safe methods for performing these
procedures and a method of postoperative management that pro-
vides an accelerated recovery.
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